February 10, 2012: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Roster

Contents

• Members
• FDA Participants
• FDA Administrative Staff

---

Members

• Steven M. Dubinett, M.D., Chair
  Professor of Medicine and Pathology
  Division of Pulmonary and Critical Care Medicine
  David Geffen School of Medicine at the
  University of California, Los Angeles
  10833 Le Conte Avenue, 37-131 CHS
  Los Angeles, CA 90095
• Scott P. Bruder, M.D., Ph.D. *
  Senior Vice President and Chief Science and
  Technology Officer
  Becton, Dickinson & Company
  1 Becton Drive
  Franklin Lakes, NJ 07417
• Linda A. Dahlgren, D.V.M., Ph.D., DACVS
  Associate Professor
  Department of Large Animal Clinical Sciences
  Virginia-Maryland Regional College of
  Veterinary Medicine
  Virginia Polytechnic Institute and State University
  Phase II, Duck Pond Road
  Blacksburg, VA 24061
• Steven A. Goldman, M.D., Ph.D.
  Rykenboer Professor and Chairman
  Department of Neurology
  University of Rochester
  601 Elmwood Avenue, MRB/Box 645
  Rochester, NY 14642
• Francis J. Hornicek, Ph.D., M.D. +
  Chief
  Orthopedic Oncology Services
  Massachusetts General Hospital
  Yawkey Building, Suite 3700
  55 Fruit Street
  Boston, MA 02114
• Tabassum Ahsan, Ph.D.
  Assistant Professor
  Department of Biomedical Engineering
  Center for Stem Cell Research and Regenerative
  Medicine
  Tulane University
  500 Lindy Boggs
  New Orleans, LA 70118
• Larry A. Couture, Ph.D.
  Senior Vice President
  Center for Applied Technology Development
  Beckman Research Institute
  City of Hope
  1500 E. Duarte Road
  Duarte, CA 91711
• Evanthia Galanis, M.D.
  Professor
  Department of Molecular Medicine
  Mayo Clinic
  200 First Street SW
  Rochester, MN 55905
• Patrick Hwu, M.D.
  Professor
  Department of Melanoma Medical Oncology
  Division of Cancer Medicine
  University of Texas M.D. Anderson Cancer Center
  1515 Holcombe Boulevard, Unit 430
  Houston, TX 77030
• Peter L. Saltonstall**
  President
  National Organization for Rare Disorders
  55 Kenosia Avenue, PO Box 1968
  Danbury, CT 06813
• Mei-Ling Ting Lee, Ph.D.
  Professor
  Department of Epidemiology and Biostatistics
  Biostatistics and Risk Assessment Center
  University of Maryland School of Public Health
  SPH Building 255, EPIB, Room 2234R
  College Park, MD 20742
• Evan Y. Snyder, M.D., Ph.D.
  Professor
  Program in Stem Cells and Regenerative Biology
  Sanford-Burnham Medical Research Institute
  10901 North Torrey Pines Road, Rm. 7261
  La Jolla, CA 32037

* Industry Representative
** Consumer Representative
+ Not Attending

---

FDA Participants

• Carolyn Wilson, Ph.D.
  Associate Director for Research
  Center for Biologics Evaluation and Research Food and Drug Administration
  1401 Rockville Pike, HFM-21
  Rockville, MD 20852
• Suzanne Epstein, Ph.D.
  Associate Director for Research
  Office of Cellular, Tissue and Gene Therapies
  Center for Biologics Evaluation and Research
  Food and Drug Administration
  1401 Rockville Pike, HFM-730
  Rockville, MD 20852
• Steven Bauer, Ph.D.
  Chief
  Cellular, and Tissue Therapy Branch
  Division of Cellular and Gene Therapies
  Office of Cellular, Tissue and Gene Therapies
  Center for Biologics Evaluation and Research
  1401 Rockville Pike, HFM 740
  Rockville, MD 20852
• Deborah Hursh, Ph.D.
  Senior Investigator
  Cellular and Tissue Therapy Branch
  Division of Cellular and Gene Therapies
  Office of Cellular, Tissue and Gene Therapies
  Center for Biologics Evaluation and Research
  1401 Rockville Pike, HFM-740
  Rockville, MD 20852
• Stephanie Simek, Ph.D.
  Deputy Director
  Office of Cellular, Tissue and Gene Therapies
  Center for Biologics Evaluation and Research
  Food and Drug Administration
  1401 Rockville Pike, HFM-700
  Rockville, MD 20852
• Raj Puri, M.D., Ph.D.
  Director
  Division of Cellular and Gene Therapies
  Office of Cellular, Tissue and Gene Therapies
  Center for Biologics Evaluation and Research
  1401 Rockville Pike, HFM-740
  Rockville, MD 20852
• Brenton McCright, Ph.D.
  Senior Investigator
  Cellular and Tissue Therapy Branch
  Division of Cellular and Gene Therapies
  Office of Cellular, Tissue and Gene Therapies
  Center for Biologics Evaluation and Research
  1401 Rockville Pike, HFM-740
  Rockville, MD 20852
• Brian Stultz, M.S.
  Biologist
  Cellular and Tissue Therapy Branch
  Division of Cellular and Gene Therapies
  Office of Cellular, Tissue and Gene Therapies
  Center for Biologics Evaluation and Research
  1401 Rockville Pike, HFM-740
  Rockville, MD 20852
• Malcolm Moos, M.D., Ph.D.
  Senior Investigator
  Cellular and Tissue Therapy Branch
  Division of Cellular and Gene Therapies
  Office of Cellular, Tissue and Gene Therapies
  Center for Biologics Evaluation and Research
  1401 Rockville Pike, HFM-730
  Rockville, MD 20852
• John Thomas, Ph.D.
  Staff Scientist
  Cellular and Tissue Therapy Branch
  Division of Cellular and Gene Therapies
  Office of Cellular, Tissue and Gene Therapies
  Center for Biologics Evaluation and Research
  1401 Rockville Pike, HFM-730
  Rockville, MD 20852

---

FDA Administrative Staff

• Designated Federal Officer
  Gail Dapolito
  Division of Scientific Advisors and Consultants
  Center for Biologics Evaluation and Research
  Food and Drug Administration
  1401 Rockville Pike, HFM-71
  Rockville, MD 20852
  Phone: (301) 827-1289
  E-Mail: gail.dapolito@fda.hhs.gov
• Committee Management Specialist
  Sheryl Clark, M.B.A.
  Division of Scientific Advisors and Consultants
  Center for Biologics Evaluation and Research
  Food and Drug Administration
  1401 Rockville Pike, HFM-71
  Rockville, MD 20852
  Phone: (301) 827-2715
  E-Mail: sheryl.clark@fda.hhs.gov